Literature DB >> 3260623

Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery.

K Hongo1, N F Kassell, T Nakagomi, T Sasaki, T Tsukahara, H Ogawa, D G Vollmer, R M Lehman.   

Abstract

Vascular contractions in response to KCl and serotonin (5-hydroxytryptamine, 5-HT) in rabbit basilar artery were studied in vitro using an isometric tension-measurement technique. Hemoglobin (10(-5)M) markedly augmented contractions induced by 5-HT (10(-9) to 10(-6)M) and slightly augmented those induced by KCl (20 to 80 mM) in arteries with intact endothelium. On the other hand, the augmentation induced by hemoglobin was almost abolished in arteries that were chemically denuded of endothelial cells by pretreatment with saponin. Since hemoglobin is known to be a selective inhibitor of endothelium-derived relaxing factor (EDRF), it is possible that the augmentation of contraction by hemoglobin in endothelium-intact arteries was mediated via an inhibition of spontaneously released EDRF. The effect of subarachnoid hemorrhage (SAH) on spontaneously released EDRF was investigated by injecting 5 ml of blood into the cisterna magna and sacrificing the rabbits 2 days later. Arteries after SAH showed a significant reduction in hemoglobin-induced augmentation compared to that seen in control arteries with intact endothelium. This result suggests that spontaneously released EDRF is significantly reduced after SAH. It is concluded that EDRF is released spontaneously in the rabbit basilar artery and that inhibition of its release might be involved in pathogenesis of cerebral vasospasm.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260623     DOI: 10.3171/jns.1988.69.2.0247

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

Review 1.  Clinical relevance of endothelium-derived relaxing factor (EDRF).

Authors:  E Bassenge
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

Review 2.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

3.  Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage.

Authors:  V Friedrich; R Flores; A Muller; F A Sehba
Journal:  Neuroscience       Date:  2009-10-25       Impact factor: 3.590

4.  [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.

Authors:  Michael Zimmermann; Carla Sabine Jung; Hartmut Vatter; Andreas Raabe; Volker Seifert
Journal:  Neurosurg Rev       Date:  2002-11-19       Impact factor: 3.042

5.  Cerebrovascular effects of substance P after experimental subarachnoid haemorrhage.

Authors:  A Pasqualin; T Tsukahara; K Hongo; O Van Beek; N F Kassell; J C Torner
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 6.  Inflammatory Pathways Following Subarachnoid Hemorrhage.

Authors:  Kevin Min Wei Khey; Alec Huard; Sherif Hanafy Mahmoud
Journal:  Cell Mol Neurobiol       Date:  2019-12-05       Impact factor: 5.046

Review 7.  To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Authors:  Giulia Cossu; Mahmoud Messerer; Mauro Oddo; Roy Thomas Daniel
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.